Literature DB >> 14998864

Management of primary resistance to gemcitabine and cisplatin (G-C) chemotherapy in metastatic bladder cancer with HER2 over-expression.

D Amsellem-Ouazana, P Beuzeboc, M Peyromaure, A Viellefond, M Zerbib, B Debre.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14998864     DOI: 10.1093/annonc/mdh112

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  2 in total

1.  Central Nervous System Metastasis in Patients With Urothelial Carcinoma: Institutional Experience and a Comprehensive Review of the Literature.

Authors:  Leonidas N Diamantopoulos; Ali R Khaki; Guru P Sonpavde; Vyshak A Venur; Evan Y Yu; Jonathan L Wright; Petros Grivas
Journal:  Clin Genitourin Cancer       Date:  2019-12-05       Impact factor: 2.872

2.  Clinical Significance of ErbB Receptor Family in Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-Analysis.

Authors:  Yuh-Shyan Tsai; Hong-Lin Cheng; Tzong-Shin Tzai; Nan-Haw Chow
Journal:  Adv Urol       Date:  2012-09-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.